EDITORIAL COMMENT

Urology. 2020 Mar:137:6. doi: 10.1016/j.urology.2019.11.052.
No abstract available

Publication types

  • Comment

MeSH terms

  • Advisory Committees
  • Pharmaceutical Preparations*
  • United States
  • United States Food and Drug Administration
  • Urology*

Substances

  • Pharmaceutical Preparations